The Vocational School of Upper Valais offers a wide range of basic vocational training, inter-company courses, vocational matriculation and continuing vocational education. Every week, about 2000 apprentices from 58 professions, 200 teachers and numerous trainers, parents and guests enter and leave the two sites in Brig and Visp. The BioArk Visp site hosts the life science offerings, including training for laboratory assistants in biology and chemistry.
The Bonding and Financing Centre (CCF) is the financial service provider of the Valais Economic Development Agency. CCF AG sees itself as a competence center in the service of Valais companies and is an important source of financing for them.
Curio Biotech is a young CRO providing personalized Contract Research Services to Clients in Pharma/Nutrition and Cosmetic sectors. Services: In vitro – Drug Discovery, Pre-clinical Studies, Efficacy, Safety, Pharmocology, Mechanism of Action, Bioanalytics to Biopharma (Quality Control) sector. It can services on biocompatibility of medical devices.
Kodiak Sciences is a biopharmaceutical company focused on novel therapies for the treatment of high-prevalence chronic eye diseases. The company is based in Palo Alto, California. A development team of Kodiak Sciences is based in Visp.
Lonza is a preferred global partner to the pharmaceutical, biotech and nutrition markets. The company works to enable a healthier world by supporting its customers to deliver new and innovative medicines that help treat a wide range of diseases. Lonza achieves this by combining technological insight with world-class manufacturing, scientific expertise and process excellence.
MINTworld is an educational initiative of the Lonza Visp and the Canton of Valais. At the Lonza site in Visp, a world of experience will be 2023, a world of experience will be created at the Lonza site in Visp. In this world, schoolchildren and young people will be inspired by the topics of mathematics, information technology, natural sciences and technology.
Messenger RNA is not a new technology, but we’re constantly discovering new ways to use it to treat and prevent disease. Since our founding in 2010, Moderna have established the industry’s first mRNA technology platform.
CMO for pharmaceutical companies for filling & Finish of vials, capsules and disposable syringes under sterile conditions ensuring the highest quality, the highest security, fully cGMP compliant.
Active monitoring combined with familiarity with specific tools, established industrial experience plus a particular openness to innovation mean that CimArk SA can respond to the questions asked by any entrepreneur keen to ensure that their enterprise functions properly.
Monthey Site
Rte de l’Ile-au-bois 1A
CH-1870 Monthey
Tél. +41 (0) 58 332 21 20
info@bioark.ch
Massimo Nobile
